DBV Technologies S.A.
DBVTF- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001613780
In the last 90 days, DBV Technologies S.A. insiders filed 0 open-market purchases and 1 sale; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesDBVT
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $1.25K in total
- 1
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding DBVTF, Q2 2026
No superinvestor reported holding DBVTF at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by DBV Technologies S.A. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 (view filing)4:15 PM ET | Jul 29 | 2 days | Mohideen PharisChief Medical Officer | SSale | −464 | $2.70 | −$1.25K | −0.3%144.5K after | |
| Feb 2, 2026 (view filing) | Jan 29 | 4 days | Mohideen PharisChief Medical Officer | SSale | −534 | $4.86 | −$2.60K | −0.4%145.0K after | |
| Dec 19, 2025 (view filing)4:04 PM ET | Dec 17-18 | 2 days | Caisse Des Depots Et Consignations and 4 othersOther: Member of 10% owner group | SSale | −3.37M | $4.60 | −$15.5M | −31.6%7.30M after | 3 lots |
| Nov 25, 2025 (view filing) | Nov 20-21 | 5 daysLate | Mohideen PharisChief Medical Officer | SSale | −8.12K | $2.86 | −$23.2K | −7.4%101.5K after | 2 lots |
| Jul 31, 2025 (view filing) | Jul 29 | 2 days | Mohideen PharisChief Medical Officer | SSale | −464 | $2.22 | −$1.03K | −0.4%109.6K after | |
| May 27, 2025 (view filing) | May 22 | 5 days | Mohideen PharisChief Medical Officer | SSale | −397 | $1.84 | −$730.48 | −0.4%110.1K after | |
| Jan 31, 2025 (view filing) | Jan 30 | 1 day | Mohideen PharisChief Medical Officer | SSale | −600 | $0.85 | −$510 | −0.5%110.5K after | |
| Nov 27, 2024 (view filing) | Nov 22-25 | 5 daysLate | Mohideen PharisChief Medical Officer | SSale | −907 | $0.5549 | −$503.31 | −0.8%111.1K after | 2 lots |
| Nov 25, 2024 (view filing) | Nov 21 | 4 days | Mohideen PharisChief Medical Officer | SSale | −2.35K | $0.54 | −$1.27K | −2.1%112.0K after | |
| Jul 31, 2024 (view filing) | Jul 29 | 2 days | Mohideen PharisChief Medical Officer | SSale | −1.78K | $0.98 | −$1.75K | −2.2%79.4K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in DBV Technologies S.A. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding DBVTF in 13F filings for Q2 2026.